Cancer Admission Score Prediction Model: A prediction model that calculates the chance for a patient to be admitted after triage and after first blood results
Study summary
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
* Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.
Exclusion Criteria:
* \<18 years old
* Only received a surgical intervention as cancer treatment
* Admitted to the ED for the surgical department
Primary outcome measure(s)
Cancer Admission Score — Through study completion, an average of 6 months Cancer Admission Score (CAS) calculated after triage and after first blood results, ranging from 0 to 100%. The higher the score the greater the change of admission
Disposition — Through study completion, an average of 6 months The outcome of a visit to the ED, being either admission or home
Agreement between the CAS and the actual disposition — Through study completion, an average of 6 months Agreement between the CAS predicted outcome and the actual outcome
Trial sites (1)
Facility
City
Region
Status
Erasmus University Medical Center
Rotterdam
South Holland
Recruiting
More Erasmus Medical Center trials in the Netherlands
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
